Pantherna Therapeutics presented at the RNA Therapeutics Conference in London, UK

Dr. Klaus Giese provided an outline of Pantherna’s therapeutic programs how to tackle vascular leakage in the lung caused by viral infection i.e. Corona virus (SARS-CoV-2) and Influenza.